drugset / Trial / NCT00740064
Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To evaluate the efficacy and safety of Raltegravir and Epzicom over 48 weeks in ART-naive HIV-infected subjects.
Timeline
- Start
- 2008-05
- Primary completion
- 2009-08
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abacavir/Lamivudine | Unknown | — | — |
| Subject | Raltegravir | Other / unclassified | 400 mg | — |